Covered recipient · General Payments record
RYAN EATON
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$2,309.98
- Reported across 86 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $506.20 | 17 |
| Education | $29.60 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Globus Medical, Inc. | $329.65 | 3 |
| ABBVIE INC. | $161.16 | 13 |
| E.R. Squibb & Sons, L.L.C. | $29.60 | 2 |
| Amgen Inc. | $15.39 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.93 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103673806 | CMS |
| ABBVIE INC. | $23.24 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103673808 | CMS |
| ABBVIE INC. | $14.70 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103673810 | CMS |
| ABBVIE INC. | $9.10 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103673812 | CMS |
| ABBVIE INC. | $10.11 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103673814 | CMS |
| ABBVIE INC. | $10.73 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103673816 | CMS |
| ABBVIE INC. | $12.62 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103673818 | CMS |
| ABBVIE INC. | $9.14 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103673820 | CMS |
| ABBVIE INC. | $11.70 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103673822 | CMS |
| ABBVIE INC. | $10.23 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103673824 | CMS |
| ABBVIE INC. | $7.39 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103673826 | CMS |
| ABBVIE INC. | $10.18 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103673828 | CMS |
| ABBVIE INC. | $11.09 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103673830 | CMS |
| Amgen Inc. | $15.39 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117546714 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.80 | 01/25/2024 | Education | Undisputed | 01/23/2026 | 1101581051 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.80 | 02/26/2024 | Education | Undisputed | 01/23/2026 | 1101581066 | CMS |
| Globus Medical, Inc. | $153.00 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145016281 | CMS |
| Globus Medical, Inc. | $137.78 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145016283 | CMS |
| Globus Medical, Inc. | $38.87 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145016287 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.